Spinifex raises $6.3M; RXi gets green light for late-stage NeuVax study;

@FierceBiotech: Study aims decode baby DNA, create analysis tools. Story | Follow @FierceBiotech

@JohnCFierce: And now for something completely different. Russian agency backs upstart nano-bio with tailored pricing plan. Item | Follow @JohnCFierce

@RyanMFierce: @LifeSciVC (Bruce Booth) analyzes our shrinking biotech eco system, 27% drop in biopharmas over past 5 years Article | Follow @RyanMFierce

@MaureenFierce: RT @ldtimmerman: What most biotechies are missing on Twitter: A huge networking opportunity. Article | Follow @MaureenFierce

> Australia's Spinifex has raised $6.3 million from GBS Venture Partners and Brandon Capital Partners, bringing its total venture haul to $22.3 million. Story

> RXi Pharmaceuticals says that the FDA has lifted a partial clinical hold that had been delaying a late-stage study of its lead treatment NeuVax. RXi release

> Immunovaccine named Novavax veteran John J. Trizzino as its new chief executive officer. Novavax release

> Silence Therapeutics has forged a pact with InteRNA Technologies B.V. to develop novel microRNA therapeutics for cancer. Release

> Amicus Therapeutics and GlaxoSmithKline have begun dosing patients in a registration study comparing the efficacy of Amigal (migalastat HCl) and enzyme replacement therapy for the treatment of Fabry disease. Release

Pharma News

> Chinese outcry over Harbin unit's glitzy headquarters. Report

> FDA panel wants bone drugs' labeling changed, but how? Story

> Industry funding for CME falls 31% to $830M. Article

Biotech IT News

> Study aims decode baby DNA, create analysis tools. Article

> Scientists explore new model in battle against kidney disease. Report

> CLC bio building bioinformatics foundation for $4M cancer project. More

> U.K. groups building genomic cloud. Story

> Microsoft video-game tech used to detect illness. More

Medical Device News

> Valeritas completes $150M Series C round. News

> Masimo hit with patent lawsuit. Piece

> Cochlear shares take a dive on news of recall. Report

> Panel mulls tougher rules for transvaginal meshes. Item

And Finally... AVI staffers found inspiration for their work in the new Hollywood hit "Contagion." Story

Suggested Articles

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.

Johns Hopkins researchers developed a biodegradable polymer to transport large therapies into cells—including genes and even CRISPR.

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.